At TechCrunch's sold-out StrictlyVC event in San Francisco on Thursday night, we covered a lot of ground in a short time, ...

First-in-Class enVVe system to be evaluated in TAVVE U.S. Pivotal TrialClinical site activation and patient enrollment expected to commence later this yearLarge unmet clinical need for approximately 3 ...

Pomerantz LLP is investigating claims on behalf of investors of Replimune Group, Inc. (“Replimune” or the “Company”) (NASDAQ: REPL). Such investors are ...

Tragic circumstances are at least generally natural or accidental.

The average one-year price target for Replimune Group (NasdaqGS:REPL) has been revised to $5.04 / share. This is a decrease of 59.94% from the prior estimate of $12.58 dated April 12, 2026. The price ...

Amjad Masad said that young people who are not deeply interested in computer science should not study it.

MANILA, Philippines — Almost a hundred barangays in Batangas province have yet to receive their assistance from the national ...

Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced multiple presentations at the 2026 American ...

Strip away the theatre — including the surreal moment when Israel’s Foreign Ministry summoned Spain’s chargé d’affaires over an Andalusian “Burning of Judas” effigy of Netanyahu stuffed with gunpowder ...